HER2 expression of this patient was heterogeneous (ranging from IHC 0 in the initial biopsy to IHC 1+ in the residual tumor and 2+ in a lymph node and bladder lesion, all with negative FISH), consistent with an overall HER2-low phenotype. Here, ERBB2 is linked to neoplasm.